|
Nimotuzumab in tumors of head and neck .Phase IV |
2013-02-01 |
CIMAB |
|
Therapeutic clinical evaluation of the Plectranthus amboinicus Lour Spreng (Oregano French) tablets in patient with common cold |
2011-11-22 |
CIDEM |
|
Effectiveness and safety of ior®EPOCIM in Chronic Kidney Disease patients in pre-dialysis. |
2011-11-11 |
CIMAB |
|
MAGINC Study |
2011-07-12 |
CIGB |
|
HeberproGen Study |
2011-05-20 |
CIGB |
|
TS-FARMEV Study |
2011-05-16 |
CIGB |
|
Early use of surfacen in the respiratory distress syndrome of the newborn. Phase IV |
2011-04-18 |
CENSA |
|
NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II. |
2010-12-29 |
CIM |
|
hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma. |
2010-12-29 |
CIM |
|
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment. |
2010-12-29 |
CIM |
|
h-R3 MaB and radiotherapy in pediatric patients with intrinsic diffuse astrocytomas of brain stem, phase II. |
2010-12-28 |
CIM |
|
Hebervis administration in patients suffering from buccal mucositis caused by chemotherapy [unsealed |
2010-12-27 |
CIGB |
|
CIGB-128 administration to patients with surgically-treated keloids. |
2010-12-24 |
CIGB |
|
AntiCEA M3-I |
2010-12-20 |
CIGB |
|
99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II |
2010-12-17 |
CIM |
|
NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III. |
2010-12-17 |
CIM |
|
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency. |
2010-09-27 |
CIGB |
|
THERESA-3 Study |
2009-12-11 |
CIGB |
|
rTMS-stroke-phase I |
2009-05-29 |
CIREN |
|
Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. |
2009-02-11 |
CIGB |
